D-1033-2020 Class II Terminated
FDA drug recall D-1033-2020 was initiated by Sun Pharmaceutical Industries, Inc. on Mar 13, 2020 and is designated Class II. Reason for recall: CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions. The recall status is terminated (terminated Feb 9, 2021). Affected quantity: 172,320 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 25, 2020
- Initiation Date
- Mar 13, 2020
- Termination Date
- Feb 9, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 172,320 bottles
Product description
Doxycycline Capsules, USP, 100 mg, 50-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901; Distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 63304-616-50.
Reason for recall
CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.
Distribution pattern
Nationwide in the USA
Code information
Lot #: 3983720, Exp 10/2020; 3990461, 3990464, 3990465, 3990466, 3990470, Exp 11/2020; AA42499, AA42510, AA44468, AA44470, Exp 04/2021; AA55073, AA55074, AA55075, Exp 05/2021; AA61486, Exp 06/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1033-2020
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026